Evaluation of Prime-boost Anti-pneumococcal Vaccination in Patients With Diffuse Large B Cell Lymphoma Treated With Rituximab
Clinical trial NCT04214444 · COMPLETED
Trial details
- NCT number
- NCT04214444
- Sponsor
- University Hospital, Tours
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-07-03
- Primary completion
- 2024-05-14
- Enrollment
- 26
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.